| |
Latest 10 SEC filings (by transaction date) for ONCT within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 10/24 | Apr 8/24 | Wills Robert James | Direct Ownership | Common Stock | P - Open market or private purchase | 3,086 | $8.96 |
Apr 1/24 | Mar 28/24 | Wills Robert James | Direct Ownership | Common Stock | P - Open market or private purchase | 6,914 | $8.48 |
Feb 27/24 | Feb 23/24 | Hale David F | Indirect Ownership | Common Stock | P - Open market or private purchase | 266 | $9.04 |
Feb 27/24 | Feb 23/24 | Hale David F | Direct Ownership | Common Stock | P - Open market or private purchase | 714 | $9.04 |
Feb 27/24 | Feb 23/24 | Wills Robert James | Direct Ownership | Common Stock | S - Open market or private sale | -980 | $9.04 |
Feb 15/24 | Feb 14/24 | Breitmeyer James B | Indirect Ownership | Stock Option | A - Grant, award or other under Rule 16b-3(d) | 6,200 | |
Feb 15/24 | Feb 14/24 | Breitmeyer James B | Direct Ownership | Stock Option | A - Grant, award or other under Rule 16b-3(d) | 28,400 | |
Feb 15/24 | Feb 14/24 | Leavitt Chase C. | Direct Ownership | Stock Option | A - Grant, award or other under Rule 16b-3(d) | 14,200 | |
Feb 15/24 | Feb 14/24 | Krishnan Rajesh | Direct Ownership | Stock Option | A - Grant, award or other under Rule 16b-3(d) | 17,700 | |
Feb 15/24 | Feb 14/24 | Yazji Salim | Direct Ownership | Stock Option | A - Grant, award or other under Rule 16b-3(d) | 14,200 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for ONCT within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 10/24 | Apr 8/24 | Wills Robert James | Direct Ownership | Common Stock | P - Open market or private purchase | 3,086 | $8.96 |
Apr 1/24 | Mar 28/24 | Wills Robert James | Direct Ownership | Common Stock | P - Open market or private purchase | 6,914 | $8.48 |
Feb 27/24 | Feb 23/24 | Hale David F | Indirect Ownership | Common Stock | P - Open market or private purchase | 266 | $9.04 |
Feb 27/24 | Feb 23/24 | Hale David F | Direct Ownership | Common Stock | P - Open market or private purchase | 714 | $9.04 |
Feb 27/24 | Feb 23/24 | Wills Robert James | Direct Ownership | Common Stock | S - Open market or private sale | -980 | $9.04 |
Feb 15/24 | Feb 14/24 | Breitmeyer James B | Indirect Ownership | Stock Option | A - Grant, award or other under Rule 16b-3(d) | 6,200 | |
Feb 15/24 | Feb 14/24 | Breitmeyer James B | Direct Ownership | Stock Option | A - Grant, award or other under Rule 16b-3(d) | 28,400 | |
Feb 15/24 | Feb 14/24 | Leavitt Chase C. | Direct Ownership | Stock Option | A - Grant, award or other under Rule 16b-3(d) | 14,200 | |
Feb 15/24 | Feb 14/24 | Krishnan Rajesh | Direct Ownership | Stock Option | A - Grant, award or other under Rule 16b-3(d) | 17,700 | |
Feb 15/24 | Feb 14/24 | Yazji Salim | Direct Ownership | Stock Option | A - Grant, award or other under Rule 16b-3(d) | 14,200 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Medpace Holdings (OQ:MEDP) |
United Therapeutics (OQ:UTHR) |
Disc Medicine (OQ:IRON) |